Developing a personalized treatment rule based on a score for administering macrolide combination therapy versus beta-lactam monotherapy for patients with moderate community-acquired pneumonia employing machine learning

Introduction: Selecting the appropriate antibiotics treatment against moderate pneumonia is still a matter of debate. To develop a treatment rule for the decision of a beta-lactam monotherapy or a Macrolide beta-lactam combination therapy, we develop machine learning (ML) methods based on scoring models, [for full text, please go to the a.m. URL]